Marc is a successful pharmaceutical executive with a proven track record in commercializing pharmaceuticals and probiotics. Marc's expertise spans various therapeutic areas, including oncology, gastroenterology, companion animal health, neonatology, and live biotherapeutics and his specialization in probiotics and live biotherapeutics distinguishes him in the industry. Marc has navigated complex live biotherapeutic product development programs from planning to regulatory submission.